بدء الوقاية في الهيموفيليا أ الشديدة — المرضى غير المعالجين سابقاً

References

DOI: 10.1016/j.jtha.2024.05.026

• In previously untreated individuals with severe hemophilia A who will start prophylaxis with a plasma-derived or standard half-life recombinant FVIII concentrate, the ISTH Hemophilia Guideline Panel suggests initial prophylaxis with plasma-derived FVIII over standard half-life recombinant FVIII concentrate (conditional recommendation, based on very low–certainty evidence ⨁◯◯◯).
• Initial prophylaxis refers to the first 50 exposure days to FVIII.